Chamber and committees

I refer the member to the answer to question S6W-01510 on 4 August 2021. I can now update that the cervical screening marketing campaign was launched on 11 October 2021. Although the primary focus of this campaign will be on encouraging those eligible to attend their cervical screening appointment when invited, the campaign will also provide information on screening intervals and the benefits of testing for human papilloma virus. Beyond this campaign, we will continue to work with our partners to identify further opportunities to communicate these important messages.

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The NHS Recovery Plan sets out how we will take forward our aim of increasing NHS capacity by at least 10% in order to address the backlog of care and meet the ongoing healthcare needs of the country. The plan, backed by more than £1 billion of investment, focuses on providing alternative pathways of care that allow people to be treated more quickly and closer to home.

As part of this the Centre for Sustainable Delivery (CfSD) is working with all Health Boards to support better use of the Active Clinical Referral Triage and Discharge Patient Initiated Review to ensure patients who need to be seen get access to the care they require in a timely manner. There is work ongoing with a number of Health Boards to implement the Digital Dermatology app, which allows patients to interact with a clinician at a time convenient to the patient and without needing to attend a hospital site.

There is also considerable work underway to educate the nursing workforce with regards to skin conditions, in order to maximise the capability of this group of staff to support patients. This will, in turn, help to maximise capacity for dermatology services.

Finally, the Dermatology Pathways app provides clinically validated pathway information to GPs and other health professionals for many of the most common skin conditions, with the aim of supporting access for patients who most need treatment in the most appropriate care setting. As part of this CfSD, is working with the British Association of Dermatologists to increase the number of pathways covered by this approach.

Public Health Scotland (PHS) do not hold sub specialty data for Dermatology, this information would be held by Health Boards.

We expect NHS Boards to adhere to current guidelines on the treatment options from authorative sources such as The Scottish Intercollegiate Guidelines Network guidelines - Diagnosis and management of psoriasis and psoriatic arthritis in adults. (SIGN Guideline No 121) . Further information is also available on NHS Inform website . We also work closely with third sector organisation such as Versus Arthritis.

The Government understands that those with long term health conditions such as psoriasis and psoriatic arthritis may also need support to deal with the impact this may have on their mental wellbeing.

GPs or local healthcare teams are best placed to offer further advice or treatment if needed and we’d advise people to contact their GP if they have concerns. Further information outlining this is available on our NHS Inform website at NHS Inform.

Improving timely access to local care and support for mental health is an existing priority. As of 1 January 2021, through action 15 of the Mental Health Strategy 2017-27 and the Primary Care Improvement Fund, 193 additional Mental Health Worker posts have been created in GP settings.

We’ve also made a longer term commitment that by 2026, every GP Practice will have access to a mental health and wellbeing service, funding 1,000 additional dedicated staff who can help grow community mental health resilience and offer social prescribing opportunities on a wide range of different community based services such as arts and cultural activities, green space and physical activity and leisure etc.

Later this year, and on the basis of local plans submitted by Integration Authorities, we will start providing funding to begin national implementation of a new model for Mental Health in Primary Care.

I refer the member to the answer to question S6W-02924 on 28 September 2021. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

This information is not collected centrally.

I refer the member to the answer to question S6W-02919 on‎ 27 September 2021. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

Diagnostic information on osteoporosis, or on medical adherence, is not centrally held by Public Health Scotland. Patients are not routinely tracked year on year and so this analysis is not available. In addition, medicines that are commonly prescribed for osteoporosis may also be prescribed for other conditions.

The number of prescriptions for drugs commonly used for osteoporosis in 2020-21 was 495,340, received by 76,898 individuals. These data relates to community dispensing only. In addition, calcium and vitamin D supplements are also widely used as part of prevention and treatment for osteoporosis.

Scottish Government recommends that patients regularly review their medication with their physician to ensure that their medication plan continues to be appropriate for their conditions and needs. A GP or pharmacist should be consulted if a patient is considering stopping a course of prescribed medication.

We expect NHS Boards to ensure that people with osteoporosis, including those who may be awaiting a bone-density scan, have timely access to high-quality care as set out in the SIGN guideline Management of osteoporosis and the prevention of fragility fractures.

On 25 August we launched our NHS Recovery Plan which is backed by more than £1bn of investment over the next five years. The plan sets out how we will invest more than £400m to create a network of 10 National Treatment Centres across Scotland, increasing capacity for planned elective procedures and diagnostic care. The plan takes forward our aim of increasing NHS capacity by at least 10% as quickly as possible in order to address the backlog of care and meet the ongoing healthcare needs for people across the country.

Scotland is the second country in the world, after New Zealand, with 100 per cent Fracture Liaison Service provision across all 14 Health Boards.

Our NHS Recovery Plan, published on 25 August, outlines that the Centre for Sustainable Delivery will work collaboratively with Health Boards, health and social care partners, third sector, academia and industry to identify and implement improvements to care pathways across Scotland. This will include extending new approaches to delivering care that minimise the requirement for patients to travel, and provide services more efficiently – for example virtual appointments and virtual fracture clinics.